In essence, our experimental findings validated that NUPR1 binding to KDM3A reduces H3K9me2 levels and enhances TFEB transcription, leading to increased autophagy and augmenting TMZ resistance in hypoxia-treated glioma cells (Fig. 8). The gene discussed is KDM3A; the disease is glioma.